Rohto Pharmaceutical Co.,Ltd. (4527.T) JPX

Currency In JPY

AD

Valuation

Market Cap544.01B
Enterprise Value517.44B
P/E Ratio19.24
PEG Ratio-6.29
Price/Sales Ratio1.8
Price/Book Ratio2.06
Enterprise/Revenue1.73
Enterprise/EBITDA9.52

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.09
Operating Margin0.12
AD

Management Effectiveness

Return On Assets0.07
Return On Equity0.11

Income Statement

Revenue343.73B
Revenue/Share1,563.9
Gross Profit182.96B
EBITDA65.48B
Net Income34.25B
Diluted EPS145.29

Balance Sheet

Total Cash84.77B
Total Cash/Share375.15
Total Debt58.1B
Total Debt/Equity0.19
Current Ratio2.17
Book Value Per Share1,453.6

Price History

52-Week Change13.63
52-Week High3,122
52-Week Low2,218.5
Moving Average 50 Days2,859.18
Moving Average 200 Days2,544.47

Statistics

Average Volume1.31M
Shares Outstanding225.96M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate50
Trailing Annual Dividend Yield1.77
Payout Ratio0
Last Split Factor2:1
Last Split DateDecember 29, 2022
AD